Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. We employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. In our view, these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society. Marc Schneidman, Founder & CIO, has over 20 years of dedicated investing experience across the biotechnology universe.
| Website | http://www.aquilocap.com |
| Employees | 3 (2 on RocketReach) |
| Industry | Investment Management |
| Web Rank | 16 Million |
| Keywords | Biotechnology Investment, Life Sciences Venture Capital, Biotech Venture Capital, Pharmaceutical Investment, Drug Development Funding, Healthcare Venture Capital, Clinical Stage Investment, Healthcare Portfolio Management |
| Competitors | Fidelity Investments, BlackRock, Vanguard, PIMCO, T. Rowe Price, J.P. Morgan, ステート・ストリート・グローバル・アドバイザーズ（株）, Invesco Ltd., Schwab Advisor Services, Goldman Sachs Commercial Mortgage Capital +32 more (view full list) |
Looking for a particular Aquilo Capital Management employee's phone or email?
Aquilo Capital Management Questions
Brian Polzak is the Co-Founder of Aquilo Capital Management.
2 people are employed at Aquilo Capital Management.
Top Aquilo Capital Management Employees
-
Brian Polzak
Co-Founder at Aquilo Capital Management
Chapel Hill, NC, US5 -
Adam Bristol
Director of Investments at Aquilo Capital Management
San Francisco, CA, US25
Related Companies
